In this study, high JWA or XRCC1 mRNA expression was correlated with longer overall survival in all the patients or in subgroups treated with different regimens and emerged as the independent prognostic factors for ESCC patients in this cohort. The gene discussed is ARL6IP5; the disease is esophageal squamous cell carcinoma.